`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________________________
`
`MYLAN PHARMACEUTICALS INC.
`
`and
`
`DR. REDDY’S LABORATORIES, INC.,
`
`Petitioner
`
`v.
`
`POZEN INC. and HORIZON PHARMA USA, INC.
`
`Patent Owners
`____________________________
`
`Case No. IPR2017-019951
`U.S. Patent No. 9,220,698
`____________________________
`
`PETITIONER’S MOTION FOR WITHDRAWAL OF COUNSEL
`
`
`1 Petitioner Dr. Reddy’s Laboratories, Inc., from IPR2018-00894, has been joined
`as a Petitioner to this proceeding
`
`
`
`I.
`
`Statement of Precise Relief Requested
`Pursuant to 37 C.F.R. § 42.10(e) Mylan Pharmaceuticals Inc. (“Mylan”)
`
`
`
`hereby respectfully requests that the Patent Trial and Appeal Board (the “Board”)
`
`authorize the withdrawal of Robert D. Swanson, back up counsel in this matter.
`
`Patent Owner has stated it will not oppose this motion. The Board granted
`
`permission to file this motion during a telephonic hearing held on January 24,
`
`2019.
`
`II.
`
`Statement of Facts Showing Good Cause for the Board to Authorize
`Withdrawal
`Under 37 C.F.R. § 42.10(e), counsel may not withdraw from a proceeding
`
`without authorization from the Board. On April 2, 2018, Mylan submitted a pro
`
`hac vice application for Mr. Swanson which was granted by the Board on June 11,
`
`2018 (Paper 39). Mylan then submitted its Updated Mandatory Notices listing Mr.
`
`Swanson as additional back up counsel on June 18, 2018 (Paper 43). Mr. Swanson
`
`is no longer associated with the firm Perkins Coie LLP, therefore Mylan
`
`respectfully requests the Board’s authorization to withdraw Mr. Swanson as an
`
`additional back up counsel in this proceeding. Mylan will continue to be
`
`represented by lead counsel, Brandon M. White, a registered practitioner.
`
`III. Conclusion
`For the foregoing reasons, Mylan respectfully requests that the Board
`
`authorize the withdrawal of Robert D. Swanson in this proceeding.
`
`- 1 -
`
`
`
`Dated: January 24, 2019
`
`
`
`
`
`
`
`/Brandon M. White/
`Brandon M. White
`Reg. No. 52,354
`
`PERKINS COIE LLP
`700 13th Street, NW, Suite 600
`Washington, D.C. 20005
`Telephone: (202) 654-6204
`Facsimile: (202) 654-6211
`Email: bmwhite@perkinscoie.com
`
`Attorney for Mylan Pharmaceuticals Inc.
`
`
`
`- 2 -
`
`
`
`CERTIFICATE OF SERVICE
`The undersigned hereby certifies that the foregoing: PETITIONER’S
`
`
`
`MOTION FOR WITHDRAWAL OF COUNSEL was served electronically via
`
`email as follows:
`
`
`Patent Owners:
`
`Thomas A. Blinka
`Jonathan G. Graves
`Susan Krumplitsch
`Ellen Scordino
`Lauren Krickl
`Cooley LLP
`zIPR2017-01995@cooley.com
`
`Margaret J. Sampson
`Stephen M. Hash
`Jeffrey S. Gritton
`Baker Botts LLP
`pozen-
`vimovoBB@bakerbotts.com
`
`Dated: January 24, 2019
`
`Petitioner Dr. Reddy’s:
`
`Alan H. Pollack
`Dmitry V. Shelhoff
`Stuart D. Sender
`Louis H. Weinstein
`apollack@buddlarner.com
`dshelhoff@buddlarner.com
`ssender@buddlarner.com
`lweinstein@buddlarner.com
`
`
`
`
`
`
`
`
`/Brandon M. White/
`Brandon M. White
`
`Attorney for Mylan Pharmaceuticals Inc.
`
`
`
`
`
`